The parents of a child recently diagnosed with Duchenne's muscular dystrophy want to know if their infant twin daughters should be tested for the disease too. Which response by the nurse is the most appropriate?
A.
"No, Duchenne's muscular dystrophy is a sex-linked genetic disorder rarely affecting females."
B.
"No, infants the age of your daughters are too young to undergo testing for Duchenne's muscular dystrophy."
C.
"Yes, the earlier the diagnosis of any type of muscular dystrophy is made, the better the child's quality of life."
D.
"Yes, females are equally likely to have Duchenne's muscular dystrophy as are boys."
ANS: A
Duchenne's muscular dystrophy is a sex-linked recessive disease that usually only affects males. Females with Turner's syndrome, in which the child only inherits one X chromosome from the mother, can be affected, but females are usually carriers. The infant twin daughters do not need to be tested.
You might also like to view...
The nurse is caring for an older client with depression who has begun having trouble sleeping
In addition to antidepressants, a safe, nonpharmacologic and potentially effective adjunctive treatment for insomnia in persons with a diagnosis of depression is: 1. Medical meditation. 2. Watching TV. 3. Progressive relaxation. 4. Alternate-nostril breathing.
The critical care nurse is caring for a patient who has had an MI. The nurse should expect to assist with establishing what hemodynamic monitoring procedure to assess the patient's left ventricular function?
A) Central venous pressure (CVP) monitoring B) Pulmonary artery pressure monitoring (PAPM) C) Systemic arterial pressure monitoring (SAPM) D) Arterial blood gases (ABG)
Health disparities are unequal burdens of disease morbidity and mortality rates experienced by racial and ethnic groups that are often exacerbated by which of the following? (Select all that apply.)
a. Social status b. Economics c. Environment d. Improved access to health care
Which of the following drugs is the angiotensin-converting enzyme (ACE) inhibitor of choice for slowing progression of chronic renal failure (CRF) to end-stage renal disease (ESRD)?
a. Captopril (Capoten) b. Benazepril (Lotensin) c. Enalapril (Vasotec) d. Lisinopril (Prinivil)